MoneyWorks4Me

Onesource Specialty Pharma informs about updates

16 May 2026 Evaluate
Onesource Specialty Pharma has informed that the Government of Karnataka has accorded in-principle approval for the application submitted by the Company for Unit-II expansion project under the Karnataka Industrial Policy (KIP) 2025-30, towards incentives and concessions.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1753.95
Dr. Reddys Labs. 1239.00
Cipla 1329.90
Lupin 1928.00
Zydus Lifesciences 1135.00
View more..